Valo et al., 2010 - Google Patents
Multifunctional hydrophobin: toward functional coatings for drug nanoparticlesValo et al., 2010
- Document ID
- 2201586624503091107
- Author
- Valo H
- Laaksonen P
- Peltonen L
- Linder M
- Hirvonen J
- Laaksonen T
- Publication year
- Publication venue
- Acs Nano
External Links
Snippet
Efficient delivery of nanosized drug formulations to the desired body sites is not always reached despite the rapid development of pharmaceutical nanotechnologies. In spite of the undoubted effect of the size for increased bioavailability and controlled drug delivery …
- 239000002105 nanoparticle 0 title abstract description 199
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valo et al. | Multifunctional hydrophobin: toward functional coatings for drug nanoparticles | |
| Haider et al. | Nanostructured lipid carriers for delivery of chemotherapeutics: A review | |
| Jacob et al. | Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy—an overview on recent advances | |
| Habibi et al. | Protein nanoparticles: uniting the power of proteins with engineering design approaches | |
| Sivadasan et al. | Cubosomes in drug delivery—a comprehensive review on its structural components, preparation techniques and therapeutic applications | |
| Kashapov et al. | Self-assembly of amphiphilic compounds as a versatile tool for construction of nanoscale drug carriers | |
| Kumari et al. | Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs | |
| Musielak et al. | Synthesis and potential applications of lipid nanoparticles in medicine | |
| Wilkosz et al. | Molecular insight into drug-loading capacity of PEG–PLGA nanoparticles for itraconazole | |
| Verma et al. | Protein based nanostructures for drug delivery | |
| Dandamudi et al. | Chitosan-coated PLGA nanoparticles encapsulating triamcinolone acetonide as a potential candidate for sustained ocular drug delivery | |
| Bodratti et al. | Formulation of poloxamers for drug delivery | |
| Weissmueller et al. | Nanocarriers from GRAS zein proteins to encapsulate hydrophobic actives | |
| Karimi et al. | Albumin nanostructures as advanced drug delivery systems | |
| Yang et al. | Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo | |
| Umar et al. | Cubosomes: design, development, and tumor-targeted drug delivery applications | |
| Fuhrmann et al. | Modular design of redox-responsive stabilizers for nanocrystals | |
| Almomen et al. | The design of anionic surfactant-based amino-functionalized mesoporous silica nanoparticles and their application in transdermal drug delivery | |
| Oliveira et al. | A versatile nanocarrier—cubosomes, characterization, and applications | |
| Gao et al. | Stereoselective stabilization of polymeric vitamin E conjugate micelles | |
| Vadakkan et al. | Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage | |
| Guzmán Rodríguez et al. | Smart polymeric micelles for anticancer hydrophobic drugs | |
| Pippa et al. | Insulin/poly (ethylene glycol)-block-poly (L-lysine) Complexes: Physicochemical Properties and Protein Encapsulation | |
| Wu et al. | Controlling nucleation and fabricating nanoparticulate formulation of sorafenib using a high-gravity rotating packed bed | |
| Wang et al. | Programming self-assembly of tobacco mosaic virus coat proteins at Pickering emulsion interfaces for nanorod-constructed capsules |